Global Cord Blood Corporation (CORBF)
OTCMKTS
· Delayed Price · Currency is USD
1.250
-0.500 (-28.57%)
Oct 28, 2024, 10:02 AM EDT
Global Cord Blood Revenue
In the fiscal year ending March 31, 2022, Global Cord Blood had annual revenue of 1.24B CNY with 7.21% growth. Global Cord Blood had revenue of 297.21M in the quarter ending March 31, 2022, a decrease of -1.69%.
Revenue
1.24B CNY
Revenue Growth
+7.21%
P/S Ratio
0.77
Revenue / Employee
1.03M CNY
Employees
1,202
Market Cap
167.39M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2022 | 1.24B | 83.62M | 7.21% |
Mar 31, 2021 | 1.16B | -61.82M | -5.06% |
Mar 31, 2020 | 1.22B | 234.71M | 23.79% |
Mar 31, 2019 | 986.75M | 49.99M | 5.34% |
Mar 31, 2018 | 936.77M | 176.79M | 23.26% |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Mar 31, 2014 | Pro | Pro | Pro |
Mar 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 108.78M |
Global Cord Blood News
- 4 months ago - Global Cord Blood Corporation Investors With Losses Are Urged By The Schall Law Firm To Start Communication Be Mindful Of The Deadline In This Case - Accesswire
- 4 months ago - The Schall Law Firm Encourages Global Cord Blood Corporation Investors With Losses To Initiate Communication Be Conscious Of The Time Limit In This Situation - Accesswire
- 4 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBF - PRNewsWire
- 4 months ago - CO, CORBF DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF - GlobeNewsWire
- 4 months ago - CORBF Investors Have Opportunity to Join Global Cord Blood Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
- 4 months ago - Investors Who Have Incurred Losses In Global Cord Blood Corporation Are Encouraged By The Schall Law Firm To Reach Out Please Be Mindful Of The Deadline In This Matter - Accesswire
- 4 months ago - Investors Who Have Sustained Losses In Global Cord Blood Corporation Are Urged By The Schall Law Firm To Make Contact Please Be Aware Of The Deadline In This Case - Accesswire
- 4 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF - GlobeNewsWire